Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2018

Open Access 01-12-2018 | Study protocol

Electroacupuncture to treat with Overactive Bladder in Postmenopausal Women: study protocol for a multicenter, randomized, controlled, parallel clinical trial

Authors: Eun-Young Nam, Ju-Yeon Park, Junyoung Jo, Seung-Hyun Jung, Chi-Yeon Lim, Dong-Il Kim

Published in: Trials | Issue 1/2018

Login to get access

Abstract

Background

Electroacupuncture has been used for treatment in patients with overactive bladder. This study was conducted to evaluate the efficacy and safety of electroacupuncture for treating overactive bladder of postmenopausal women.

Methods/design

This is a multicenter, randomized controlled, parallel clinical trial. Two hundred ninety participants with overactive bladder syndrome will be recruited from Dongguk University Bundang Oriental Hospital and Cheonan Korean Medicine Hospital of Daejeon University and randomly allocated into one of two groups in a 1:1 ratio. One group will receive electroacupuncture (EA) and the other acupuncture (AC). The allocation will be concealed from both participants and assessors. The study period will be about 10 weeks, including 6 weeks of electroacupuncture or acupuncture treatment and a four week follow-up period. Both EA group and AT group will undergo acupuncture at 7 fixed points, and the EA group will undergo electronic stimulation at 6 points. The primary outcome will be the average number of micturitions per 24 h based on a 3-day bladder diary. The secondary outcome will comprise the 3-day bladder diary, the overactive bladder symptom score and the results of the King’s health questionnaire.

Discussion

The results of this trial will provide information regarding the efficacy and safety of electroacupuncture for treating overactive bladder in postmenopausal women.

Trial registration

ClinicalTrials.gov, NCT03260907. Registered on 24 August 2017.
Appendix
Available only for authorised users
Literature
1.
Temml C, Heidler S, Ponholzer A, Madersbacher S. Prevalence of the overactive bladder syndrome by applying the International Continence Society definition. Eur Urol. 2005;48:622–7.CrossRef
2.
Coyne KS, Sexton CC, Kopp ZS, Ebel-Bitoun C, Milsom I, Chapple C. The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: results from EpiLUTS. BJU Int. 2011;108:1459–71.CrossRef
3.
Haylen B, de Ridder D, Freeman R, Swift S, Berghmans B, Lee J, Monga A, Petri E, Rizk D, Sand P. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. J Assoc Chart Physiother Womens Health. 2012;110:33.
4.
Gormley EA, Lightner DJ, Burgio KL, Chai TC, Clemens JQ, Culkin DJ, Das AK, Foster HE, Scarpero HM, Tessier CD. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J Urol. 2012;188:2455–63.CrossRef
5.
Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, Van Kerrebroeck P, Victor A, Wein A. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003;61:37–49.CrossRef
6.
Sang JH, Park HM. Survey on the prevalence of overactive bladder in healthy Korean postmenopausal women. J Kor Soc Menopause. 2012;18:60–6.CrossRef
7.
Milsom I, Abrams P, Cardozo L, Roberts R, Thüroff J, Wein A. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int. 2001;87:760–6.CrossRef
8.
Kim Y-J, Kim M-C, Lee C-H, Kim J-U, Yook T-H. The effect of needle-embedding therapy and pharmacopuncture therapy on patients with urinary incontinence. J Acupunct Meridian Stud. 2011;4:220–4.CrossRef
9.
Choi M-S, Kim D-I. A Study on Korean Medical Clinical Management of Female Overactive Bladder. J Korean Obstet Gynecol. 2014;27:83–102.CrossRef
10.
Kim D, Choi C, Ahn I, Ryu I, Choi M, Lee Y, Lee MS. Efficacy and safety of Baweidihuang-wan in women with overactive bladder: a randomized, double blind, placebo controlled trial. Int J Clin Exp Med. 2014;7:2744.PubMedPubMedCentral
11.
Han J-S. Acupuncture analgesia: areas of consensus and controversy. Pain. 2011;152:S41–8.CrossRef
12.
Burnstock G. Acupuncture: a novel hypothesis for the involvement of purinergic signalling. Med Hypotheses. 2009;73:470–2.CrossRef
13.
Stewart F, Berghmans B, Bø K, Glazener CM. Electrical stimulation with non-implanted devices for stress urinary incontinence in women. Cochrane Database Syst Rev 2016;10:CD012390.
14.
Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 2010;8:18.CrossRef
15.
MacPherson H, Altman DG, Hammerschlag R, Youping L, Taixiang W, White A, Moher D. Revised standards for reporting interventions in clinical trials of acupuncture (STRICTA): extending the CONSORT statement. J Evid Based Med. 2010;3:140–55.CrossRef
16.
Homma Y, Yoshida M, Seki N, Yokoyama O, Kakizaki H, Gotoh M, Yamanishi T, Yamaguchi O, Takeda M, Nishizawa O. Symptom assessment tool for overactive bladder syndrome—overactive bladder symptom score. Urology. 2006;68:318–23.CrossRef
17.
Yamaguchi O, Nishizawa O, Takeda M, Yokoyama O, Homma Y, Kakizaki H, Obara K, Gotoh M, Igawa Y, Seki N. Clinical guidelines for overactive bladder. Int J Urol. 2009;16:126–42.CrossRef
18.
Kelleher CJ, Cardozo LD, Toozs-Hobson PM. Quality of life and urinary incontinence. Curr Opin Obstet Gynecol. 1995;7:404–8.CrossRef
19.
Kelleher C, Cardozo L, Khullar V, Salvatore S. A new questionnaire to assess the quality of life of urinary incontinent women. BJOG. 1997;104:1374–9.CrossRef
20.
Reese PR, Pleil AM, Okano GJ, Kelleher CJ. Multinational study of reliability and validity of the King's Health Questionnaire in patients with overactive bladder. Qual Life Res. 2003;12:427–42.CrossRef
21.
Carmona MVO, Molleja ÁMG, Ríos IL, Torronteras AR, Tamajón VMC, Obrero IG. Neuroestimulación percutánea del nervio tibial posterior frente a neuroestimulación de B 6 (Sanyinjiao) en incontinencia urinaria de urgencia. Revista Internacional de Acupuntura. 2013;7:124–30.CrossRef
22.
van BALKEN MR, Vandoninck V, Gisolf KW, Vergunst H, Kiemeney LA, Debruyne FM, Bemelmans BL. Posterior tibial nerve stimulation as neuromodulative treatment of lower urinary tract dysfunction. J Urol. 2001;166:914–8.CrossRef
23.
Klingler H, Pycha A, Schmidbauer J, Marberger M. Use of peripheral neuromodulation of the S3 region for treatment of detrusor overactivity: a urodynamic-based study. Urology. 2000;56:766–71.CrossRef
24.
Peters KM, MacDiarmid SA, Wooldridge LS, Leong FC, Shobeiri SA, Rovner ES, Siegel SW, Tate SB, Jarnagin BK, Rosenblatt PL. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial. J Urol. 2009;182:1055–61.CrossRef
25.
MacDiarmid SA, Peters KM, Shobeiri SA, Wooldridge LS, Rovner ES, Leong FC, Siegel SW, Tate SB, Feagins BA. Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder. J Urol. 2010;183:234–40.CrossRef
26.
Vandoninck V, van Balken MR, Agró EF, Petta F, Caltagirone C, Heesakkers JP, Kiemeney LA, Debruyne FM, Bemelmans BL. Posterior tibial nerve stimulation in the treatment of urge incontinence. Neurourol Urodyn. 2003;22:17–23.CrossRef
27.
Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Am J Obstet Gynecol. 2002;187:116–26.CrossRef
28.
Abrams P, Blaivas JG, Stanton SL, Andersen JT. The standardisation of terminology of lower urinary tract function. The International Continence Society Conunittee on Standardisation of Terminology. Scand J Urol Nephrol Suppl. 1988;114:5–19..
29.
Philp T, Shah P, Worth P. Acupuncture in the treatment of bladder instability. BJU Int. 1988;61:490–3.CrossRef
30.
Paik SH, Han SR, Kwon OJ, Ahn YM, Lee BC, Ahn SY. Acupuncture for the treatment of urinary incontinence: A review of randomized controlled trials. Exp Ther Med. 2013;6:773–80.CrossRef
Metadata
Title
Electroacupuncture to treat with Overactive Bladder in Postmenopausal Women: study protocol for a multicenter, randomized, controlled, parallel clinical trial
Authors
Eun-Young Nam
Ju-Yeon Park
Junyoung Jo
Seung-Hyun Jung
Chi-Yeon Lim
Dong-Il Kim
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Trials / Issue 1/2018
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-018-2715-3

Other articles of this Issue 1/2018

Trials 1/2018 Go to the issue

Study protocol

Clinical evaluation of modified transalveolar sinus floor elevation and osteotome sinus floor elevation in posterior maxillae: study protocol for a randomized controlled trial

Study protocol

SImplification of Medications Prescribed to Long-tErm care Residents (SIMPLER): study protocol for a cluster randomised controlled trial

Study protocol

The impact of manual rotation of the occiput posterior position on spontaneous vaginal delivery rate: study protocol for a randomized clinical trial (RMOS)

Study protocol

Assessment of the effect of addition of 24 hours of oral tranexamic acid post-operatively to a single intraoperative intravenous dose of tranexamic acid on calculated blood loss following primary hip and knee arthroplasty (TRAC-24): a study protocol for a randomised controlled trial

Study protocol

Efficacy and safety of electroacupuncture for post stroke depression: study protocol for a randomized controlled trial

Study protocol

Physical Rehabilitation Core Outcomes In Critical illness (PRACTICE): protocol for development of a core outcome set